Latest Alpha Tau Medical News & Updates

See the latest news and media coverage for Alpha Tau. We track all announcements, press releases, and industry mentions in real time, all in one place.

Alpha Tau Medical (Alpha Tau)

Developer of alpha radiation therapy for cancer

alphatau.com

Headquarters: Jerusalem , Israel
Founded year: 2016
Company type: Private company
Number of employees: 100–200

Last updated Today

Latest news about Alpha Tau Medical (Alpha Tau)

In short: Alpha Tau announced strong glioblastoma trial results, secured a $35M strategic partnership with Tolmar, and received regulatory approval in Japan.

Company announcements

June 11 Alpha Tau

Alpha Tau receives FDA clearance for glioblastoma trial enrollment

The clearance follows an interim report showing 100% local disease control; two new U.S. sites were authorized.

June 3 Alpha Tau

Alpha Tau and Tolmar announce strategic collaboration

Partnership brings AlphaDaRT therapy to U.S. urological cancer patients with $15M manufacturing investment and up to $161.5M milestones.

June 1 Alpha Tau

Alpha Tau reports strong overall survival from pancreatic cancer studies

Pooled analysis of three Phase I/II studies shows encouraging median overall survival across patient populations with favorable safety profile.

May 18 Alpha Tau

Alpha Tau announces first quarter 2026 results and update

The company reported a net loss of $22.9 million and highlighted clinical progress including REGAIN trial results and ReSTART enrollment completion.

Media coverage

June 11 Yahoo Finance

Alpha Tau Receives FDA Clearance to Complete Enrollment in REGAIN Recurrent Glioblastoma Trial and Add Two U.S. Clinical Sites; Early Interim Results Showed 100% Local Disease ...

Following the pre-specified interim safety report and overwhelming demand from clinicians to treat patients as quickly as possible, Alpha Tau to resume recruitment immediately for...

June 3 Yahoo Finance

Alpha Tau Announces Strong Overall Survival Results from Alpha DaRT® Pancreatic Cancer Studies Presented at 2026 ASCO Annual Meeting

Results reinforce the potential feasibility and safety of Alpha DaRT as a one-time, minimally invasive intratumoral treatment that fits naturally into the patient journey ...

June 3 Yahoo Finance

DRTS Stock Shot Up A Whopping 22% Today – Why A $196.5M Prostate Cancer Deal Got Investors Buzzing

Alpha Tau signed an agreement with Tolmar to commercialize its lead cancer therapy for prostate cancer in the United States.

June 1 Yahoo Finance

Alpha Tau Announces Strong Overall Survival Results from Alpha DaRT® Pancreatic Cancer Studies Presented at 2026 ASCO Annual Meeting

Results reinforce the potential feasibility and safety of Alpha DaRT as a one-time, minimally invasive intratumoral treatment that fits naturally into the patient journey ...

Never miss news about Alpha Tau

Track Alpha Tau and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.